Antisecretory effects of Librax in patients with duodenal ulcer.
D002707:Chlordiazepoxide / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D011812:Quinuclidines / Q000627:therapeutic use
D010276:Parasympatholytics; D010919:Placebos; D011812:Quinuclidines; D002707:Chlordiazepoxide